PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes

Rhea-AI Summary

PrestoDoctor (OTCQB: DOGP subsidiary) announced expansion into Michigan on October 21, 2025, adding telehealth evaluations and patient-management services in a state facing major tax changes.

Michigan currently has a 10% excise plus 6% sales tax (~16% total); legislation expected January 1, 2026 would add a 24% wholesale tax, potentially raising effective tax burdens and pressuring retail sales. State projections cited a roughly 14% decline in retail cannabis sales. Medical purchases remain subject only to the 6% sales tax, creating a price gap that could increase demand for medical certifications. PrestoDoctor says its HIPAA-compliant telehealth platform and patient management will support patients and operators through the transition.

Positive

• Footprint: Now operating in 20 states
• Platform: HIPAA-compliant telehealth evaluations available statewide
• Medical vs recreational: Medical purchases avoid 10% excise tax

Negative

• New tax: Expected 24% wholesale tax effective Jan 1, 2026
• Sales impact: State projects ~14% decline in retail cannabis sales
• Higher retail prices: Additional tax likely to raise consumer prices

Strategic market entry positions company for growth as Michigan prepares for 2026 tax reforms

Mesquite, NV, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV — October 21, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP) subsidiary PrestoDoctor, a national leader in cannabis telehealth and patient-care certification services, today announced its official expansion into the State of Michigan. This move marks a significant step in the company’s strategy to grow its footprint across key regulated cannabis markets, providing telemedicine evaluations and patient-wellness services that connect licensed physicians with qualified cannabis patients statewide.

“Our mission at PrestoDoctor has always been to ensure safe, compliant, and accessible medical cannabis evaluations,” said David Tobias, CEO of Dogecoin Cash, Inc. (OTC: DOGP), parent company of PrestoDoctor. “Michigan represents both a mature and evolving market, and with the state’s regulatory and tax landscape shifting significantly, our timing could not be better to help patients and operators navigate those changes.”

Strategic Context: Rising Cannabis Taxes & Market Implications

Michigan currently imposes a 10% excise tax on recreational cannabis sales, in addition to the 6% state sales tax, for a total retail tax burden of about 16%. Beginning January 1, 2026, legislation is expected to introduce a 24% wholesale tax on cannabis products, potentially raising the effective total tax rate to one of the highest in the United States.

Economic analysts have cautioned that this additional tax burden will likely increase retail prices while dampening overall sales activity. State fiscal projections anticipate a decline in retail cannabis sales of roughly 14%, reflecting consumer price sensitivity and the challenge for operators to maintain margins in a higher-tax environment.

By contrast, medical cannabis dispensaries in Michigan do not charge the 10% excise tax that applies to recreational purchases. Medical patients pay only the standard 6% state sales tax, meaning their total tax burden is less than half that faced by recreational consumers. As the new wholesale tax takes effect, this pricing gap could make medical certifications more economically advantageous for patients—potentially renewing interest in the state’s medical cannabis program.

Tobias added, “With Michigan’s cannabis taxes set to rise sharply on January 1, 2026, the companies that prepare now—by tightening compliance systems, optimizing patient engagement, and improving digital efficiency—will be the ones that remain competitive. PrestoDoctor is here to support that transition and ensure that patients continue to have access to affordable, regulated medical cannabis care in now 20 states across the nation.”

What PrestoDoctor Brings to Michigan

• Telehealth evaluations connecting licensed physicians with patients seeking medical cannabis certification or renewals through a secure HIPAA-compliant platform.
• Integrated patient-management services that streamline scheduling, documentation, and follow-up care, enabling operators and physicians to focus on quality outcomes.

Why Michigan?

• Michigan remains one of the largest cannabis markets in the U.S., generating billions in annual sales.
• The upcoming tax increase heightens the need for efficient, technology-driven solutions that help patients and operators manage higher costs.
• PrestoDoctor’s entry supports Michigan’s goal of strengthening the regulated marketplace and ensuring continued access to licensed medical professionals.

About PrestoDoctor

PrestoDoctor, a 51% owned subsidiary of Dogecoin Cash, Inc. (OTC: DOGP), is a leading telehealth provider specializing in medical cannabis evaluations and patient-wellness certification. The company connects patients with licensed physicians through a secure online platform, offering compliant, confidential, and convenient access to medical cannabis recommendations in multiple U.S. states.

About Dogecoin Cash, Inc. (OTCQB: DOGP)
Dogecoin Cash, Inc. is a publicly traded company with operations that include telehealth services through its subsidiary PrestoDoctor. For more information and Company disclosures, visit OTC Markets.

Investor & Media Contact
Dogecoin Cash, Inc.
Info@dogecoincashinc.com

Forward-Looking Statements: This release contains “forward-looking statements” within the meaning of federal securities laws, including statements regarding the timing, availability, scope, and expected benefits of PrestoDoctor’s services in Michigan and other markets. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including changes in laws or regulations, operational or licensing requirements, payer and patient adoption, competitive dynamics, and other factors described in the Company’s disclosures on OTC Markets. The Company undertakes no obligation to update forward-looking statements except as required by law.

No Offer or Solicitation: This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.

FAQ

What did PrestoDoctor (DOGP) announce on October 21, 2025 regarding Michigan?

PrestoDoctor announced expansion into Michigan, offering telehealth medical cannabis evaluations and patient-management services statewide.

When does Michigan's new 24% wholesale cannabis tax take effect and how does it change total taxes?

Legislation is expected to take effect January 1, 2026, adding a 24% wholesale tax to existing rates and materially increasing effective retail tax burdens.

How do medical cannabis taxes compare to recreational taxes in Michigan?

Medical purchases pay only the 6% state sales tax, while recreational sales face a 10% excise plus 6% sales tax (about 16% today).

How could Michigan tax changes affect demand for PrestoDoctor services (DOGP)?

The expected higher taxes could widen the price gap favoring medical purchases, potentially increasing demand for medical certifications via PrestoDoctor's telehealth platform.

What services will PrestoDoctor provide to Michigan patients and operators?

PrestoDoctor will provide secure HIPAA-compliant telehealth evaluations, certification renewals, and integrated patient-management (scheduling, documentation, follow-up).

What is the projected statewide retail sales impact from Michigan's tax changes?

State fiscal projections cited in the announcement anticipate roughly a 14% decline in retail cannabis sales following the tax increase.